Genentech, Boehringer Mannheim Corp. cardiopulmonary news

GNE filed a suit for patent infringement and a declaratory judgment of patent infringement in the U.S. District Court for the District of Massachusetts against Boehringer Mannheim GmbH and Boehringer Mannheim Corp., alleging that Reteplase tissue plaminogen activator (tPA) infringes five GNE patents covering Activase tPA.

Boehringer, which had not yet seen the filing, said it is confident that Reteplase is covered by enforceable patents because it has a different molecular structure than other thrombotic agents. ...